Prevalence and predictors of post-COVID-19 pulmonary fibrosis

Background Several studies are ongoing to obtain more information about post-COVID-19 (corona virus disease-19) pulmonary fibrosis. Old-aged patients are more likely to evolve lung fibrosis in COVID-19. Another risk factor is the degree of disease severity, including comorbidities, such as hypertens...

Full description

Bibliographic Details
Main Authors: Khaled Fawzy Alkhayat, Doaa Gadallah, Mohamed Hamed Hasan, Abdelhady Ragab Abdel-Gawad, Eman Roshdy Mohamed, Asmaa Ramadan Bakir
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Egyptian Journal of Chest Disease and Tuberculosis
Subjects:
Online Access:http://www.ejcdt.eg.net/article.asp?issn=0422-7638;year=2022;volume=71;issue=4;spage=481;epage=484;aulast=Alkhayat
_version_ 1811200650906697728
author Khaled Fawzy Alkhayat
Doaa Gadallah
Mohamed Hamed Hasan
Abdelhady Ragab Abdel-Gawad
Eman Roshdy Mohamed
Asmaa Ramadan Bakir
author_facet Khaled Fawzy Alkhayat
Doaa Gadallah
Mohamed Hamed Hasan
Abdelhady Ragab Abdel-Gawad
Eman Roshdy Mohamed
Asmaa Ramadan Bakir
author_sort Khaled Fawzy Alkhayat
collection DOAJ
description Background Several studies are ongoing to obtain more information about post-COVID-19 (corona virus disease-19) pulmonary fibrosis. Old-aged patients are more likely to evolve lung fibrosis in COVID-19. Another risk factor is the degree of disease severity, including comorbidities, such as hypertension, diabetes, as well as lab findings, for example, lymphopenia and leukocytosis. Aims of work To assess the prevalence of post-COVID-19 pulmonary fibrosis and reveal some of its predictors. Results The study included 50 patients in the outpatient clinics of Chest and EL-Helal Hospitals with a mean age of 49.6 ± 17.7 years. It included 32 (64%) males and 18 (36%) females. Pulmonary fibrosis was detected in 34 (68%) patients. Pulmonary fibrosis was bilateral in 24 patients and unilateral in 10 patients. Leucopenia, elevated serum ferritin, elevated D-dimer, and elevated C-reactive protein (CRP) were associated with pulmonary fibrosis (P value <0.001). Conclusion Pulmonary fibrosis is recognized as a complication between survivors. Immune response due to lung injury by viral infection, and trials to repair are keys to the procedure of fibro genesis. Predictors of lung fibrosis involve increased lab parameters such as serum ferritin, C-reactive protein, and D-dimer.
first_indexed 2024-04-12T02:07:13Z
format Article
id doaj.art-9d15a5bc14054e0292a3938cbe1f47d4
institution Directory Open Access Journal
issn 0422-7638
2090-9950
language English
last_indexed 2024-04-12T02:07:13Z
publishDate 2022-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Egyptian Journal of Chest Disease and Tuberculosis
spelling doaj.art-9d15a5bc14054e0292a3938cbe1f47d42022-12-22T03:52:30ZengWolters Kluwer Medknow PublicationsEgyptian Journal of Chest Disease and Tuberculosis0422-76382090-99502022-01-0171448148410.4103/ecdt.ecdt_76_21Prevalence and predictors of post-COVID-19 pulmonary fibrosisKhaled Fawzy AlkhayatDoaa GadallahMohamed Hamed HasanAbdelhady Ragab Abdel-GawadEman Roshdy MohamedAsmaa Ramadan BakirBackground Several studies are ongoing to obtain more information about post-COVID-19 (corona virus disease-19) pulmonary fibrosis. Old-aged patients are more likely to evolve lung fibrosis in COVID-19. Another risk factor is the degree of disease severity, including comorbidities, such as hypertension, diabetes, as well as lab findings, for example, lymphopenia and leukocytosis. Aims of work To assess the prevalence of post-COVID-19 pulmonary fibrosis and reveal some of its predictors. Results The study included 50 patients in the outpatient clinics of Chest and EL-Helal Hospitals with a mean age of 49.6 ± 17.7 years. It included 32 (64%) males and 18 (36%) females. Pulmonary fibrosis was detected in 34 (68%) patients. Pulmonary fibrosis was bilateral in 24 patients and unilateral in 10 patients. Leucopenia, elevated serum ferritin, elevated D-dimer, and elevated C-reactive protein (CRP) were associated with pulmonary fibrosis (P value <0.001). Conclusion Pulmonary fibrosis is recognized as a complication between survivors. Immune response due to lung injury by viral infection, and trials to repair are keys to the procedure of fibro genesis. Predictors of lung fibrosis involve increased lab parameters such as serum ferritin, C-reactive protein, and D-dimer.http://www.ejcdt.eg.net/article.asp?issn=0422-7638;year=2022;volume=71;issue=4;spage=481;epage=484;aulast=Alkhayatcovid-19d-dimerpulmonary fibrosis
spellingShingle Khaled Fawzy Alkhayat
Doaa Gadallah
Mohamed Hamed Hasan
Abdelhady Ragab Abdel-Gawad
Eman Roshdy Mohamed
Asmaa Ramadan Bakir
Prevalence and predictors of post-COVID-19 pulmonary fibrosis
Egyptian Journal of Chest Disease and Tuberculosis
covid-19
d-dimer
pulmonary fibrosis
title Prevalence and predictors of post-COVID-19 pulmonary fibrosis
title_full Prevalence and predictors of post-COVID-19 pulmonary fibrosis
title_fullStr Prevalence and predictors of post-COVID-19 pulmonary fibrosis
title_full_unstemmed Prevalence and predictors of post-COVID-19 pulmonary fibrosis
title_short Prevalence and predictors of post-COVID-19 pulmonary fibrosis
title_sort prevalence and predictors of post covid 19 pulmonary fibrosis
topic covid-19
d-dimer
pulmonary fibrosis
url http://www.ejcdt.eg.net/article.asp?issn=0422-7638;year=2022;volume=71;issue=4;spage=481;epage=484;aulast=Alkhayat
work_keys_str_mv AT khaledfawzyalkhayat prevalenceandpredictorsofpostcovid19pulmonaryfibrosis
AT doaagadallah prevalenceandpredictorsofpostcovid19pulmonaryfibrosis
AT mohamedhamedhasan prevalenceandpredictorsofpostcovid19pulmonaryfibrosis
AT abdelhadyragababdelgawad prevalenceandpredictorsofpostcovid19pulmonaryfibrosis
AT emanroshdymohamed prevalenceandpredictorsofpostcovid19pulmonaryfibrosis
AT asmaaramadanbakir prevalenceandpredictorsofpostcovid19pulmonaryfibrosis